254 related articles for article (PubMed ID: 37022178)
1. SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection.
Qu Y; Haas de Mello A; Morris DR; Jones-Hall YL; Ivanciuc T; Sattler RA; Paessler S; Menachery VD; Garofalo RP; Casola A
Microbiol Spectr; 2023 Jun; 11(3):e0037823. PubMed ID: 37022178
[TBL] [Abstract][Full Text] [Related]
2. Protective Role of Nuclear Factor Erythroid 2-Related Factor 2 Against Respiratory Syncytial Virus and Human Metapneumovirus Infections.
Ivanciuc T; Sbrana E; Casola A; Garofalo RP
Front Immunol; 2018; 9():854. PubMed ID: 29740449
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein.
De Angelis M; Anichini G; Palamara AT; Nencioni L; Gori Savellini G
Virol J; 2023 Oct; 20(1):239. PubMed ID: 37853388
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway.
Hamad RS; Al-Kuraishy HM; Alexiou A; Papadakis M; Ahmed EA; Saad HM; Batiha GE
Cell Stress Chaperones; 2023 Nov; 28(6):657-673. PubMed ID: 37796433
[TBL] [Abstract][Full Text] [Related]
5. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor.
Rodrigues D; Machado MR; Alves JV; Fraga-Silva TFC; Martins RB; Campos LCB; Francisco DF; Couto AES; Bonato VLD; Arruda E; Becari C; Auxiliadora-Martins M; Louzada-Júnior P; Costa RM; Tostes RC
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H252-H263. PubMed ID: 37327001
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor Nrf2 as a potential therapeutic target for COVID-19.
Wang Y; Ma J; Jiang Y
Cell Stress Chaperones; 2023 Jan; 28(1):11-20. PubMed ID: 36417098
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
Olagnier D; Farahani E; Thyrsted J; Blay-Cadanet J; Herengt A; Idorn M; Hait A; Hernaez B; Knudsen A; Iversen MB; Schilling M; Jørgensen SE; Thomsen M; Reinert LS; Lappe M; Hoang HD; Gilchrist VH; Hansen AL; Ottosen R; Nielsen CG; Møller C; van der Horst D; Peri S; Balachandran S; Huang J; Jakobsen M; Svenningsen EB; Poulsen TB; Bartsch L; Thielke AL; Luo Y; Alain T; Rehwinkel J; Alcamí A; Hiscott J; Mogensen TH; Paludan SR; Holm CK
Nat Commun; 2020 Oct; 11(1):4938. PubMed ID: 33009401
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of Nrf2.
Komaravelli N; Tian B; Ivanciuc T; Mautemps N; Brasier AR; Garofalo RP; Casola A
Free Radic Biol Med; 2015 Nov; 88(Pt B):391-403. PubMed ID: 26073125
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 protects against airway disorders.
Cho HY; Kleeberger SR
Toxicol Appl Pharmacol; 2010 Apr; 244(1):43-56. PubMed ID: 19646463
[TBL] [Abstract][Full Text] [Related]
10. The possible role of nuclear factor erythroid-2-related factor 2 activators in the management of Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Eldahshan OA; Abdelkhalek YM; El Dahshan M; Ahmed EA; Sabatier JM; Batiha GE
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23605. PubMed ID: 38069809
[TBL] [Abstract][Full Text] [Related]
11. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
12. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
13. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis.
Hosakote YM; Jantzi PD; Esham DL; Spratt H; Kurosky A; Casola A; Garofalo RP
Am J Respir Crit Care Med; 2011 Jun; 183(11):1550-60. PubMed ID: 21471094
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection.
Sohn SY; Hearing J; Mugavero J; Kirillov V; Gorbunova E; Helminiak L; Mishra S; Mackow E; Hearing P; Reich NC; Kim HK
mBio; 2021 Dec; 12(6):e0275621. PubMed ID: 34724828
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
16. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
J Virol; 2020 May; 94(10):. PubMed ID: 32161178
[TBL] [Abstract][Full Text] [Related]
17. Progressive Rotavirus Infection Downregulates Redox-Sensitive Transcription Factor Nrf2 and Nrf2-Driven Transcription Units.
Patra U; Mukhopadhyay U; Mukherjee A; Sarkar R; Chawla-Sarkar M
Oxid Med Cell Longev; 2020; 2020():7289120. PubMed ID: 32322337
[TBL] [Abstract][Full Text] [Related]
18. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
[TBL] [Abstract][Full Text] [Related]
19. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
20. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
